Catalyzed by the pandemic, the pharma industry quickly progressed from being digitally agnostic to a state of preparedness. The shift required the industry to experiment with technology in its customer-facing plans, which resulted – in many cases – a creation of random acts of digital, often without a cohesive overarching strategy. Can pharma do better? The answer lies in understanding the utility of their digital assets while building a mindset to transform, and ensuring that teams within the organization do not work at cross-purposes.
To discuss this and many other trends, Anup Soans, Editor-in-Chief of MedicinMan, moderated the first panel discussion on the D2: Powered by Digital, Driven by Data series with three panelists who shared their varied experiences.
First published in MedicinMan on 27th August 2022